The Valley Desk

NCT04770545 · Interventional trial

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

Overall registry status Completed

Phase 3

Conditions Geographic Atrophy Secondary to Age-related Macular Degeneration

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov